• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于血浆中纤溶酶原激活物抑制剂-1水平升高,高血压和肥胖患者存在纤溶功能受损。

Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma.

作者信息

Urano T, Kojima Y, Takahashi M, Serizawa K, Sakakibara K, Takada Y, Takada A

机构信息

Department of Physiology, Hamamatsu-University School of Medicine, Japan.

出版信息

Jpn J Physiol. 1993;43(2):221-8. doi: 10.2170/jjphysiol.43.221.

DOI:10.2170/jjphysiol.43.221
PMID:8355419
Abstract

In order to elucidate the influence of the risk factors of coronary heart disease on the fibrinolytic activity, relationships between blood pressure, body mass index (BMI), plasma lipoprotein (a) (Lp(a)) level and the plasma levels of tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) were analyzed in the subjects with mild hypertension. Systolic blood pressure showed a positive correlation with total PAI-1 and free PAI-1. Diastolic blood pressure showed no correlation with these proteins involved in the fibrinolytic system. BMI had a positive correlation with total PAI-1, free PAI-1 and euglobulin clot lysis time (ECLT). Plasma Lp(a) level showed correlation with neither blood pressure nor fibrinolytic parameters, but it showed weak negative correlation with body mass index (BMI). These results suggest that high blood pressure and obesity tend to increase free PAI-1 which reduces fibrinolytic activity. Lp(a), however, seems not to influence directly the fibrinolytic system but may work to decrease fibrinolytic activity only in conjunction with other risk factors. The effects of daily drinking of alcohol and smoking on the fibrinolytic system were also investigated in the present study and we obtained the results that habitual drinking increased plasma levels of both tPA and PAI-1 whereas smoking did not affect fibrinolytic activity. These results suggest that risk factors for coronary heart disease such as hypertension and obesity are closely related to the impaired fibrinolysis.

摘要

为了阐明冠心病危险因素对纤溶活性的影响,对轻度高血压患者的血压、体重指数(BMI)、血浆脂蛋白(a)[Lp(a)]水平与组织型纤溶酶原激活物(tPA)和纤溶酶原激活物抑制剂-1(PAI-1)血浆水平之间的关系进行了分析。收缩压与总PAI-1和游离PAI-1呈正相关。舒张压与这些参与纤溶系统的蛋白质无相关性。BMI与总PAI-1、游离PAI-1和优球蛋白凝块溶解时间(ECLT)呈正相关。血浆Lp(a)水平与血压和纤溶参数均无相关性,但与体重指数(BMI)呈弱负相关。这些结果表明,高血压和肥胖倾向于增加游离PAI-1,从而降低纤溶活性。然而,Lp(a)似乎并不直接影响纤溶系统,而可能仅与其他危险因素共同作用以降低纤溶活性。本研究还调查了每日饮酒和吸烟对纤溶系统的影响,结果发现习惯性饮酒会增加tPA和PAI-1的血浆水平,而吸烟对纤溶活性无影响。这些结果表明,高血压和肥胖等冠心病危险因素与纤溶功能受损密切相关。

相似文献

1
Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma.由于血浆中纤溶酶原激活物抑制剂-1水平升高,高血压和肥胖患者存在纤溶功能受损。
Jpn J Physiol. 1993;43(2):221-8. doi: 10.2170/jjphysiol.43.221.
2
Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.血压与纤维蛋白溶解的关系:人体测量学、代谢谱和行为变量的影响。
J Hypertens. 1995 Jun;13(6):659-66. doi: 10.1097/00004872-199506000-00013.
3
The effect of chronic allograft rejection on plasma regulators of fibrinolysis.慢性同种异体移植排斥反应对血浆纤维蛋白溶解调节因子的影响。
Ann Transplant. 2002;7(1):44-51.
4
Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.优球蛋白凝块溶解时间与组织型纤溶酶原激活物及纤溶酶原激活物抑制剂1血浆水平之间的关系。
Thromb Haemost. 1990 Feb 19;63(1):82-6.
5
Hypertension and hemostatic/fibrinolytic balance disorders.高血压与止血/纤溶平衡紊乱。
Clin Invest Med. 2009 Dec 1;32(6):E285. doi: 10.25011/cim.v32i6.10664.
6
Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.高血压与代谢性心血管综合征:特别关注绝经前女性。
J Cardiovasc Pharmacol. 1992;20 Suppl 8:S15-21.
7
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.在男性中,无论年龄、肥胖、体脂分布及相关代谢参数如何,雄激素活性较低都与促血栓形成因子的血浆水平较高相关。
Metabolism. 1997 Nov;46(11):1287-93. doi: 10.1016/s0026-0495(97)90232-8.
8
Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.中风患者体内的组织型纤溶酶原激活剂和纤溶酶原激活物抑制剂-1
Stroke. 1996 Jun;27(6):1066-71. doi: 10.1161/01.str.27.6.1066.
9
Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.科威特高脂血症患者的脂蛋白(a)、组织纤溶酶原激活物和纤溶酶原激活物抑制剂1水平
Eur J Clin Invest. 1997 May;27(5):380-6. doi: 10.1046/j.1365-2362.1997.1230671.x.
10
[Relationship of age, sex, body weight, smoking, blood lipids and fibrinolytic activities in healthy subjects].[健康受试者的年龄、性别、体重、吸烟、血脂与纤溶活性的关系]
Hunan Yi Ke Da Xue Xue Bao. 1999;24(1):65-7.

引用本文的文献

1
Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.血栓形成还是不形成?脂质与凝血的相互调节综述。
Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):533-544. doi: 10.1161/ATVBAHA.123.318286. Epub 2024 Jan 18.
2
Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19.血浆组织型纤溶酶原激活剂与COVID-19住院患者的脂蛋白(a)及临床结局相关。
Res Pract Thromb Haemost. 2023 Aug 8;7(6):102164. doi: 10.1016/j.rpth.2023.102164. eCollection 2023 Aug.
3
Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
认识到纤溶酶原激活物抑制剂1是纤维蛋白溶解的主要调节因子。
Curr Drug Targets. 2019;20(16):1695-1701. doi: 10.2174/1389450120666190715102510.
4
In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction.在年轻的心肌梗死后男性患者中,纤溶酶原激活物抑制剂-1升高与胰岛素抵抗和内皮功能障碍相关。
Heart Vessels. 2013 Sep;28(5):570-7. doi: 10.1007/s00380-012-0287-9. Epub 2012 Sep 22.